Wang QQ - Search Results

1

[Clinical Significance of Corrected Serum Calcium in 320 Patients with Multiple Myeloma].

Xu ZZ, Wu SQ, Wang QQ, Ye YM, Ma XM, Zhan R. Xu ZZ, et al. Among authors: wang qq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Aug;25(4):1058-1062. doi: 10.7534/j.issn.1009-2137.2017.04.017. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28823268 Chinese.

2

High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.

Fan L, Hong J, Huang H, Fu D, Wu S, Wang Q, Ye Y, Liu Y. Fan L, et al. Med Sci Monit. 2017 May 30;23:2636-2643. doi: 10.12659/msm.901850. Med Sci Monit. 2017. PMID: 28557972 Free PMC article.

3

Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation.

Fan L, Fu D, Zhang J, Huang H, Wang Q, Ye Y, Xie Q. Fan L, et al. Biomed Res Int. 2017;2017:5462087. doi: 10.1155/2017/5462087. Epub 2017 May 8. Biomed Res Int. 2017. PMID: 28567420 Free PMC article.

4

[A Propensity Score Matching Study of Autologous Hematopoietic Stem Cell Transplantation and New Drug Chemotherapy for Newly Diagnosed Multiple Myeloma].

Yang FY, Wang HF, Xia LH, Wang QQ, Qian CJ, He J. Yang FY, et al. Among authors: wang hf, wang qq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Feb;30(1):158-165. doi: 10.19746/j.cnki.issn.1009-2137.2022.01.026. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 35123620 Chinese.

5

[Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma].

Xie Y, Yan LZ, You T, Shi XL, Yan S, Zhai YY, Shang JJ, Yan Z, You HY, Wang QQ, Wu DP, Fu CC. Xie Y, et al. Among authors: wang qq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):505-511. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.028. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38660859 Chinese.

6

Progression of disease within 24 months (POD24) in multiple myeloma implicates poor prognosis and limitations of current prediction models for POD24.

Cao Y, Gong Y, Wang Q, Xia J, Zhou X, Sun C. Cao Y, et al. Sci Rep. 2024 Oct 1;14(1):22861. doi: 10.1038/s41598-024-73822-w. Sci Rep. 2024. PMID: 39354088 Free PMC article.

7

The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients.

You H, Jin S, Wu C, Wang Q, Yan S, Yao W, Shi X, Shang J, Yan L, Yao Y, Wang J, Wang P, Pan J, Wu D, Fu C. You H, et al. Front Oncol. 2022 Oct 7;12:938392. doi: 10.3389/fonc.2022.938392. eCollection 2022. Front Oncol. 2022. PMID: 36276097 Free PMC article.

8

Ixazomib inhibits myeloma cell proliferation by targeting UBE2K.

Wang Q, Dong Z, Su J, Huang J, Xiao P, Tian L, Chen Y, Ma L, Chen X. Wang Q, et al. Biochem Biophys Res Commun. 2021 Apr 16;549:1-7. doi: 10.1016/j.bbrc.2021.02.048. Epub 2021 Feb 26. Biochem Biophys Res Commun. 2021. PMID: 33647537 Free article.

9

Treatment for CD57-negative γδ T-cell large granular lymphocytic leukemia with pure red cell aplasia: A case report.

Xiao PP, Chen XY, Dong ZG, Huang JM, Wang QQ, Chen YQ, Zhang Y. Xiao PP, et al. Among authors: wang qq. World J Clin Cases. 2021 Sep 16;9(26):7818-7824. doi: 10.12998/wjcc.v9.i26.7818. World J Clin Cases. 2021. PMID: 34621832 Free PMC article.

10

BNIP3 overexpression may promote myeloma cell apoptosis by enhancing sensitivity to bortezomib via the p38 MAPK pathway.

Xiao P, Chen X, Dong Z, Fan W, Chen Y, Su J, Wang Q, Ma L. Xiao P, et al. Hematology. 2023 Dec;28(1):2231739. doi: 10.1080/16078454.2023.2231739. Hematology. 2023. PMID: 37401850 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters